News

本文聚焦 G 蛋白偶联受体(GPCR)与离子通道间的相互作用。详细阐述了二者在膜垂直和水平方向的信号转导机制,分析了相关复合物的结构基础,探讨了研究面临的挑战及技术进展,为理解细胞 ...
Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global G ...
这篇综述聚焦 G 蛋白偶联受体(GPCR),阐述其在 B 细胞分化、发育中的关键调控作用,以及对自身免疫性疾病发病机制的影响。还探讨了靶向 GPCR 的治疗潜力,为自身免疫性疾病研究与治疗提供 ...
17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and ...
Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily ...
The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the prevalent, often painful, chronic joint disease is aging. And like aging ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Evotec's insights into GPCRs and waveRAPID technology reveal new opportunities in drug discovery, focusing on orphan receptors and innovative screening methods. Reducing polypharmacy through ...